Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Summary

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Timeline

Start

2017-02-03

Primary completion

2018-12-06

Completion

2018-12-06

Drugs

Indications